(Q73363905)
Statements
Combination benefit of treatment with the cytokine inhibitors interleukin-1 receptor antagonist and PEGylated soluble tumor necrosis factor receptor type I in animal models of rheumatoid arthritis (English)
Bendele AM
Chlipala ES
Scherrer J
Frazier J
Sennello G
Rich WJ
Edwards CK 3rd
1 December 2000